These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 5561605)

  • 41. [Healing processes in experimental tuberculosis treated with rifampicin and ethambutol].
    Uvarova OA; Kozulitsina TI; Korotaev GA
    Probl Tuberk; 1971; 49(12):56-60. PubMed ID: 5159691
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of some rifampicin and ethambutol resistant strains of Mycobacteria isolated in the vicinity of the district of Jassy].
    Timoşca S; Petreanu V; Petreanu C; Ionescu L
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):119-25. PubMed ID: 5552548
    [No Abstract]   [Full Text] [Related]  

  • 43. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 44. [Functional state of the adrenal cortex in patients with pulmonary tuberculosis during treatment with rifampin and ethambutol].
    Rybak IuN
    Probl Tuberk; 1973; 51(10):31-3. PubMed ID: 4493156
    [No Abstract]   [Full Text] [Related]  

  • 45. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].
    Ropek M; Bielecki T; Mysakowska H; Sosnowski K; Raczyński R; Pizlo S; Majchrzak A
    Gruzlica; 1974 May; 42(5):393-5. PubMed ID: 4464225
    [No Abstract]   [Full Text] [Related]  

  • 47. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rifampicin and ethambutol in the treatment of tuberculosis in children and adolescents].
    Sibila S; Fierbinţeanu O
    Pediatria (Bucur); 1973; 22(4):361-6. PubMed ID: 4543407
    [No Abstract]   [Full Text] [Related]  

  • 49. Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    J Indian Med Assoc; 1986 Dec; 84(12):376-8. PubMed ID: 3585015
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tolerance of rifampicin and ethambutol and their effects on liver function during treatment of patients with destructive lung tuberculosis].
    Kalankhodzhaev AA; Stoianovskiĭ EA; Ginzburg VS
    Probl Tuberk; 1978 Mar; (3):19-23. PubMed ID: 652761
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effectiveness of intermittent therapy with ethambutol, rifampicin at the sanatorium stage of treatment of patients with destructive tuberculosis of the lungs].
    Navrotskiĭ VV; Tarkhova NV
    Probl Tuberk; 1977 Jan; (1):33-7. PubMed ID: 834755
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1976 Nov; (11):44-9. PubMed ID: 1019127
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of rifadin and ethambutol in pulmonary tuberculosis with concomitant diseases].
    Pak FP; Kertselli IuS
    Probl Tuberk; 1976 May; (5):78-80. PubMed ID: 951414
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pecularities of the healing process under the effect of rifampicin and ethambutol (experimental study)].
    Uvarova OA; Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):11-5. PubMed ID: 4666005
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemotherapeutic effect and pharmacokinetics of rifampicin and ethambutol].
    Drabkina RO; Ginzburg TS
    Probl Tuberk; 1975; (3):69-74. PubMed ID: 1135208
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on results of rifampicin treatment after surgical failure].
    Kekkaku; 1972 Aug; 47(8):261-8. PubMed ID: 4660854
    [No Abstract]   [Full Text] [Related]  

  • 58. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract]   [Full Text] [Related]  

  • 60. First experience with rifampicin in retreatment of resistant cases.
    Tousek J
    Acta Tuberc Pneumol Belg; 1969; 60(3):478-81. PubMed ID: 5371672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.